Primary sclerosing cholangitis (PSC) offers unique opportunities to explore the gut–liver axis
owing to the close association between liver disease and colonic inflammation. It is well …

Primary sclerosing cholangitis (PSC) was declared one of the biggest unmet needs in
hepatology during International Liver Congress 2016 in Berlin. Since then, not much has …

Management of primary or secondary sclerosing cholangitis is challenging. These Clinical
Practice Guidelines have been developed to provide practical guidance on debated topics …

Abstract Background and Aims Inflammatory bowel disease [IBD] comprises an immune-
mediated group of chronic gastrointestinal disorders. Patients with IBD may experience …

Background The optimal restorative surgical management of patients with concomitant
diagnoses of primary sclerosing cholangitis and ulcerative colitis [PSC-UC] who require …

Abstract Background and Aims Patients with primary sclerosing cholangitis and
inflammatory bowel disease [termed PSC-IBD] have a higher risk of developing colorectal …

Abstract Background and Aims Patients with inflammatory bowel diseases (IBDs) are at risk
of developing a variety of other immune-mediated inflammatory diseases (IMIDs). The …

Aims Primary sclerosing cholangitis (PSC) is a relatively common complication of ulcerative
colitis (UC). Only a few studies have investigated the impact of PSC on the clinical course of …

Objectives: The study aims to assess the effectiveness of the educational program on
patient's medication and diet adherence and to identify the relationship between the …

Introoduction: Primary sclerosing cholangitis (PSC) is a rare disease, especially in Asian
countries. PSC often develops during ulcerative colitis (UC). Little is known about the …